Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Acquires Edico Genome

NEW YORK (GenomeWeb) – Illlumina said today that it has acquired data analysis firm Edico Genome.

Edico markets its DRAGEN platform, which uses field programmable gate array technology in combination with proprietary software algorithms to reduce data footprint and enable faster speeds. Users can run DRAGEN on site, in the cloud or in a hybrid mode, and can use a variety of different cloud storage solutions and analysis pipelines.

"Our acquisition of Edico Genome is a big step toward realizing the vision of reducing sequencing data acquisition and analysis to a push-button, standardized process," Susan Tousi, senior vice president of product development at Illumina, said in a statement.  

Edico President and CEO Pieter van Rooyen added, "As the scale of sequencing expands, decreasing the cost and time of analysis will be important to fuel the clinical adoption of sequencing."

Stephen Kingsmore's group at Rady Children's Institute for Genomic Medicine has been using Edico's DRAGEN to speed up the time-to-diagnosis for its whole-genome sequencing pipeline for critically ill infants in the NICU and has developed a rapid protocol that take just under 24 hours. 

Financial details of the acquisition were not disclosed.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.